Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)
Clinical trial NCT01590225 · WITHDRAWN
Trial details
- NCT number
- NCT01590225
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-28
- Primary completion
- 2021-08-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.